Phase I clinical trial of vinorelbine (Navelbine) and trastuzumab (Herceptin) in patients with carcinoma of the breast or non-small cell lung cancer and HER-2/NEU overexpression
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2015
At a glance
- Drugs Vinorelbine (Primary) ; Trastuzumab
- Indications Advanced breast cancer; Non-small cell lung cancer
- Focus Adverse reactions
- 09 Sep 2005 New trial record.